Telaleaf, a telemedicine company transforming the access and delivery of medical cannabis care to patients, and Berlin-based medical cannabis brand Vayamed are pleased to announce a strategic partnership to strengthening the quality of telemedicine services in cannabis therapy in Germany through premium quality virtual care and to improve access, in line with Vayamed’s brand vision: “Medicine from Nature. Customized for Patients”. Vayamed and Telaleaf are driven by the vision that telemedicine will continue to move healthcare delivery from clinic to home, and will become the standard in cannabis-based medicine. Doctor visits to consult about Vayamed products and treatment options are planned as well as further programs in the field of talent support and further training at leading medical faculties nationwide.
“The importance of telemedicine in the German healthcare system will continue to grow. It offers many benefits for doctors, patients and the healthcare system, for example better access and treatment quality, qualified trainings, and improved health insurance reimbursement levels through special training offers for doctors. Together with Telaleaf, we want to improve therapies with medical cannabis in Germany through the utilization of telemedicine”, said Thimo V. Schmitt-Lord, Director New Markets & Innovation at Vayamed.
“In order to fully realize the vision of cannabis-based medicine as the advanced, alternative medicinal modality it has proven to be, Telaleaf has entirely reimagined the cannabis healthcare delivery model such that all necessary medical services, tools and resources come together for patients and doctors under one unified field. Our joint mission with Vayamed is to drive better health outcomes for patients with personalized virtual care that is sustained by expert-led medicinal cannabis training and education,” said Telaleaf CEO Gavin Treanor.
Telaleaf collaborates with leading experts such as Prof. Kirsten Müller-Vahl, M.D., and Franjo Grothenhermen, M.D., and the medical cannabis training for participating doctors is provided at the highest educational level in cooperation with Dresden International University.
Medical cannabis specialist Vayamed, a brand of Berlin-based health and life science company Sanity Group, specializes in the development and distribution of innovative cannabinoid-based medicinal products for the European market and, as a reliable provider, is committed to making medical cannabis accessible to doctors, pharmacists and patients.
Telaleaf is a telemedicine company transforming the delivery of cannabis care by connecting patients to expert doctors, trained in cannabis-based medicine, who conduct virtual medical visits and provide personalized treatment plans. Our aim is to improve patient outcomes, by improving the patient experience with high quality treatment, ease of access and expert-led training to doctors, for the most advanced virtual care in cannabis medicine.